nodes	percent_of_prediction	percent_of_DWPC	metapath
Glyburide—ABCC9—uterine cancer	0.461	1	CbGaD
Glyburide—ABCB11—Progesterone—uterine cancer	0.0506	0.134	CbGbCtD
Glyburide—ABCC1—Progesterone—uterine cancer	0.0359	0.0949	CbGbCtD
Glyburide—ABCC1—Dactinomycin—uterine cancer	0.0285	0.0753	CbGbCtD
Glyburide—ABCC3—Etoposide—uterine cancer	0.0262	0.0692	CbGbCtD
Glyburide—ABCC1—Epirubicin—uterine cancer	0.0206	0.0545	CbGbCtD
Glyburide—ABCG2—Dactinomycin—uterine cancer	0.0191	0.0504	CbGbCtD
Glyburide—ABCC3—Doxorubicin—uterine cancer	0.0179	0.0472	CbGbCtD
Glyburide—ABCC1—Etoposide—uterine cancer	0.0161	0.0425	CbGbCtD
Glyburide—ABCB11—Doxorubicin—uterine cancer	0.0154	0.0408	CbGbCtD
Glyburide—ABCC2—Carboplatin—uterine cancer	0.0142	0.0374	CbGbCtD
Glyburide—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0135	0.0356	CbGbCtD
Glyburide—ABCG2—Carboplatin—uterine cancer	0.0128	0.0339	CbGbCtD
Glyburide—ABCC2—Etoposide—uterine cancer	0.0119	0.0314	CbGbCtD
Glyburide—ABCC1—Doxorubicin—uterine cancer	0.011	0.029	CbGbCtD
Glyburide—ABCG2—Etoposide—uterine cancer	0.0108	0.0284	CbGbCtD
Glyburide—CYP2C19—Progesterone—uterine cancer	0.0107	0.0284	CbGbCtD
Glyburide—CYP2C9—Progesterone—uterine cancer	0.00893	0.0236	CbGbCtD
Glyburide—ABCB1—Progesterone—uterine cancer	0.00867	0.0229	CbGbCtD
Glyburide—ABCC2—Doxorubicin—uterine cancer	0.00812	0.0214	CbGbCtD
Glyburide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00784	0.0207	CbGbCtD
Glyburide—ABCG2—Doxorubicin—uterine cancer	0.00734	0.0194	CbGbCtD
Glyburide—ABCB1—Dactinomycin—uterine cancer	0.00687	0.0182	CbGbCtD
Glyburide—CYP3A4—Progesterone—uterine cancer	0.00519	0.0137	CbGbCtD
Glyburide—CFTR—semen—uterine cancer	0.00492	0.113	CbGeAlD
Glyburide—ABCB1—Etoposide—uterine cancer	0.00388	0.0102	CbGbCtD
Glyburide—ABCB1—Doxorubicin—uterine cancer	0.00265	0.00699	CbGbCtD
Glyburide—ABCA1—artery—uterine cancer	0.00253	0.0581	CbGeAlD
Glyburide—CYP3A4—Etoposide—uterine cancer	0.00232	0.00614	CbGbCtD
Glyburide—CFTR—exocrine gland—uterine cancer	0.00208	0.0478	CbGeAlD
Glyburide—CYP3A4—Doxorubicin—uterine cancer	0.00159	0.00419	CbGbCtD
Glyburide—ABCC9—smooth muscle tissue—uterine cancer	0.00136	0.0313	CbGeAlD
Glyburide—ABCC9—female gonad—uterine cancer	0.000957	0.022	CbGeAlD
Glyburide—CPT1A—renal system—uterine cancer	0.000956	0.0219	CbGeAlD
Glyburide—KCNJ1—renal system—uterine cancer	0.000936	0.0215	CbGeAlD
Glyburide—ABCA1—decidua—uterine cancer	0.000907	0.0208	CbGeAlD
Glyburide—CFTR—epithelium—uterine cancer	0.000907	0.0208	CbGeAlD
Glyburide—ABCA1—renal system—uterine cancer	0.000891	0.0204	CbGeAlD
Glyburide—Gliclazide—VEGFA—uterine cancer	0.000846	1	CrCbGaD
Glyburide—CFTR—renal system—uterine cancer	0.000841	0.0193	CbGeAlD
Glyburide—CPT1A—female reproductive system—uterine cancer	0.000766	0.0176	CbGeAlD
Glyburide—ABCA1—female reproductive system—uterine cancer	0.000713	0.0164	CbGeAlD
Glyburide—CPT1A—female gonad—uterine cancer	0.000697	0.016	CbGeAlD
Glyburide—CPT1A—vagina—uterine cancer	0.000692	0.0159	CbGeAlD
Glyburide—CFTR—female reproductive system—uterine cancer	0.000674	0.0155	CbGeAlD
Glyburide—ABCA1—female gonad—uterine cancer	0.000649	0.0149	CbGeAlD
Glyburide—ABCA1—vagina—uterine cancer	0.000645	0.0148	CbGeAlD
Glyburide—SLC22A7—renal system—uterine cancer	0.000622	0.0143	CbGeAlD
Glyburide—ABCC9—lymph node—uterine cancer	0.000615	0.0141	CbGeAlD
Glyburide—CFTR—female gonad—uterine cancer	0.000613	0.0141	CbGeAlD
Glyburide—ABCC8—smooth muscle tissue—uterine cancer	0.000543	0.0125	CbGeAlD
Glyburide—SLC15A1—epithelium—uterine cancer	0.000539	0.0124	CbGeAlD
Glyburide—ABCC8—renal system—uterine cancer	0.000523	0.012	CbGeAlD
Glyburide—ABCC8—endometrium—uterine cancer	0.000506	0.0116	CbGeAlD
Glyburide—SLC15A1—renal system—uterine cancer	0.0005	0.0115	CbGeAlD
Glyburide—SLC15A1—endometrium—uterine cancer	0.000483	0.0111	CbGeAlD
Glyburide—SLC15A1—mammalian vulva—uterine cancer	0.000468	0.0107	CbGeAlD
Glyburide—KCNJ11—female reproductive system—uterine cancer	0.000455	0.0104	CbGeAlD
Glyburide—CPT1A—lymph node—uterine cancer	0.000448	0.0103	CbGeAlD
Glyburide—ABCC3—decidua—uterine cancer	0.000447	0.0103	CbGeAlD
Glyburide—ABCC3—renal system—uterine cancer	0.000439	0.0101	CbGeAlD
Glyburide—ABCC1—myometrium—uterine cancer	0.000425	0.00974	CbGeAlD
Glyburide—ABCA1—lymph node—uterine cancer	0.000417	0.00958	CbGeAlD
Glyburide—SLCO2B1—decidua—uterine cancer	0.000417	0.00957	CbGeAlD
Glyburide—KCNJ11—female gonad—uterine cancer	0.000414	0.0095	CbGeAlD
Glyburide—SLCO2B1—renal system—uterine cancer	0.000409	0.00939	CbGeAlD
Glyburide—SLCO1A2—renal system—uterine cancer	0.000377	0.00865	CbGeAlD
Glyburide—SLCO2B1—uterus—uterine cancer	0.000365	0.00837	CbGeAlD
Glyburide—SLC15A1—vagina—uterine cancer	0.000362	0.00831	CbGeAlD
Glyburide—ABCC3—female reproductive system—uterine cancer	0.000352	0.00807	CbGeAlD
Glyburide—ABCG2—myometrium—uterine cancer	0.000351	0.00807	CbGeAlD
Glyburide—ABCC2—renal system—uterine cancer	0.000351	0.00805	CbGeAlD
Glyburide—SLC15A2—uterine cervix—uterine cancer	0.000334	0.00767	CbGeAlD
Glyburide—ABCC1—uterine cervix—uterine cancer	0.00033	0.00758	CbGeAlD
Glyburide—SLCO2B1—female reproductive system—uterine cancer	0.000328	0.00752	CbGeAlD
Glyburide—Blindness—Doxorubicin—uterine cancer	0.000321	0.00444	CcSEcCtD
Glyburide—ABCC3—female gonad—uterine cancer	0.00032	0.00735	CbGeAlD
Glyburide—ABCC1—decidua—uterine cancer	0.000315	0.00723	CbGeAlD
Glyburide—Eye disorder—Progesterone—uterine cancer	0.000314	0.00435	CcSEcCtD
Glyburide—SLC15A2—renal system—uterine cancer	0.000313	0.00717	CbGeAlD
Glyburide—Eruption—Epirubicin—uterine cancer	0.000312	0.00432	CcSEcCtD
Glyburide—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.000305	0.00421	CcSEcCtD
Glyburide—SLC15A2—endometrium—uterine cancer	0.000302	0.00694	CbGeAlD
Glyburide—ABCC1—endometrium—uterine cancer	0.000299	0.00686	CbGeAlD
Glyburide—SLCO2B1—female gonad—uterine cancer	0.000298	0.00685	CbGeAlD
Glyburide—Alopecia—Progesterone—uterine cancer	0.000297	0.00411	CcSEcCtD
Glyburide—Visual impairment—Medroxyprogesterone Acetate—uterine cancer	0.000294	0.00406	CcSEcCtD
Glyburide—Malnutrition—Progesterone—uterine cancer	0.000293	0.00405	CcSEcCtD
Glyburide—Erythema—Progesterone—uterine cancer	0.000293	0.00405	CcSEcCtD
Glyburide—ABCC1—mammalian vulva—uterine cancer	0.000289	0.00663	CbGeAlD
Glyburide—Eruption—Doxorubicin—uterine cancer	0.000289	0.00399	CcSEcCtD
Glyburide—Eye disorder—Medroxyprogesterone Acetate—uterine cancer	0.000285	0.00394	CcSEcCtD
Glyburide—Pancytopenia—Dactinomycin—uterine cancer	0.000282	0.0039	CcSEcCtD
Glyburide—ABCC2—female reproductive system—uterine cancer	0.000281	0.00645	CbGeAlD
Glyburide—Vision blurred—Progesterone—uterine cancer	0.000276	0.00381	CcSEcCtD
Glyburide—ABCC1—uterus—uterine cancer	0.000275	0.00632	CbGeAlD
Glyburide—Tremor—Progesterone—uterine cancer	0.000274	0.00379	CcSEcCtD
Glyburide—ABCG2—uterine cervix—uterine cancer	0.000274	0.00628	CbGeAlD
Glyburide—Anaemia—Progesterone—uterine cancer	0.000271	0.00374	CcSEcCtD
Glyburide—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.000269	0.00372	CcSEcCtD
Glyburide—Angioedema—Progesterone—uterine cancer	0.000268	0.0037	CcSEcCtD
Glyburide—KCNJ11—lymph node—uterine cancer	0.000266	0.00611	CbGeAlD
Glyburide—Malnutrition—Medroxyprogesterone Acetate—uterine cancer	0.000265	0.00367	CcSEcCtD
Glyburide—Erythema—Medroxyprogesterone Acetate—uterine cancer	0.000265	0.00367	CcSEcCtD
Glyburide—ABCG2—decidua—uterine cancer	0.000261	0.00598	CbGeAlD
Glyburide—Convulsion—Progesterone—uterine cancer	0.000254	0.00351	CcSEcCtD
Glyburide—SLC15A2—female reproductive system—uterine cancer	0.00025	0.00575	CbGeAlD
Glyburide—Myalgia—Progesterone—uterine cancer	0.000249	0.00345	CcSEcCtD
Glyburide—Arthralgia—Progesterone—uterine cancer	0.000249	0.00345	CcSEcCtD
Glyburide—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000249	0.00344	CcSEcCtD
Glyburide—ABCG2—endometrium—uterine cancer	0.000247	0.00568	CbGeAlD
Glyburide—Agranulocytosis—Dactinomycin—uterine cancer	0.000247	0.00342	CcSEcCtD
Glyburide—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000245	0.00339	CcSEcCtD
Glyburide—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000242	0.00335	CcSEcCtD
Glyburide—Confusional state—Progesterone—uterine cancer	0.000241	0.00333	CcSEcCtD
Glyburide—ABCG2—mammalian vulva—uterine cancer	0.000239	0.00549	CbGeAlD
Glyburide—Oedema—Progesterone—uterine cancer	0.000239	0.0033	CcSEcCtD
Glyburide—Hepatitis—Dactinomycin—uterine cancer	0.000238	0.00329	CcSEcCtD
Glyburide—Shock—Progesterone—uterine cancer	0.000235	0.00325	CcSEcCtD
Glyburide—Nervous system disorder—Progesterone—uterine cancer	0.000234	0.00324	CcSEcCtD
Glyburide—Hyperhidrosis—Progesterone—uterine cancer	0.000231	0.00319	CcSEcCtD
Glyburide—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00023	0.00318	CcSEcCtD
Glyburide—ABCG2—uterus—uterine cancer	0.000228	0.00523	CbGeAlD
Glyburide—Anorexia—Progesterone—uterine cancer	0.000228	0.00315	CcSEcCtD
Glyburide—SLC15A2—female gonad—uterine cancer	0.000228	0.00523	CbGeAlD
Glyburide—SLC15A2—vagina—uterine cancer	0.000226	0.0052	CbGeAlD
Glyburide—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000226	0.00312	CcSEcCtD
Glyburide—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000226	0.00312	CcSEcCtD
Glyburide—ABCC1—female gonad—uterine cancer	0.000225	0.00517	CbGeAlD
Glyburide—ABCC1—vagina—uterine cancer	0.000224	0.00514	CbGeAlD
Glyburide—Hypotension—Progesterone—uterine cancer	0.000223	0.00309	CcSEcCtD
Glyburide—Jaundice cholestatic—Epirubicin—uterine cancer	0.000219	0.00302	CcSEcCtD
Glyburide—CYP2C19—vagina—uterine cancer	0.000218	0.00501	CbGeAlD
Glyburide—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000218	0.00302	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000218	0.00301	CcSEcCtD
Glyburide—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000217	0.00299	CcSEcCtD
Glyburide—Paraesthesia—Progesterone—uterine cancer	0.000215	0.00297	CcSEcCtD
Glyburide—Dyspnoea—Progesterone—uterine cancer	0.000213	0.00295	CcSEcCtD
Glyburide—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000213	0.00295	CcSEcCtD
Glyburide—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000212	0.00294	CcSEcCtD
Glyburide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000212	0.00293	CcSEcCtD
Glyburide—Hyperbilirubinaemia—Epirubicin—uterine cancer	0.000211	0.00292	CcSEcCtD
Glyburide—Dyspepsia—Progesterone—uterine cancer	0.00021	0.00291	CcSEcCtD
Glyburide—Alopecia—Dactinomycin—uterine cancer	0.00021	0.0029	CcSEcCtD
Glyburide—Sweating increased—Etoposide—uterine cancer	0.000209	0.00289	CcSEcCtD
Glyburide—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000209	0.00289	CcSEcCtD
Glyburide—Decreased appetite—Progesterone—uterine cancer	0.000208	0.00287	CcSEcCtD
Glyburide—Erythema—Dactinomycin—uterine cancer	0.000207	0.00286	CcSEcCtD
Glyburide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000206	0.00285	CcSEcCtD
Glyburide—Gastrointestinal disorder—Progesterone—uterine cancer	0.000206	0.00285	CcSEcCtD
Glyburide—ABCC3—lymph node—uterine cancer	0.000206	0.00472	CbGeAlD
Glyburide—Pancytopenia—Etoposide—uterine cancer	0.000204	0.00282	CcSEcCtD
Glyburide—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000202	0.0028	CcSEcCtD
Glyburide—Jaundice cholestatic—Doxorubicin—uterine cancer	0.000202	0.0028	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000197	0.00273	CcSEcCtD
Glyburide—Feeling abnormal—Progesterone—uterine cancer	0.000197	0.00272	CcSEcCtD
Glyburide—Hyperbilirubinaemia—Doxorubicin—uterine cancer	0.000195	0.0027	CcSEcCtD
Glyburide—Gastrointestinal pain—Progesterone—uterine cancer	0.000195	0.0027	CcSEcCtD
Glyburide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000194	0.00269	CcSEcCtD
Glyburide—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000193	0.00267	CcSEcCtD
Glyburide—SLCO2B1—lymph node—uterine cancer	0.000192	0.0044	CbGeAlD
Glyburide—Anaemia—Dactinomycin—uterine cancer	0.000191	0.00264	CcSEcCtD
Glyburide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000191	0.00264	CcSEcCtD
Glyburide—Urticaria—Progesterone—uterine cancer	0.00019	0.00262	CcSEcCtD
Glyburide—Abdominal pain—Progesterone—uterine cancer	0.000189	0.00261	CcSEcCtD
Glyburide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000188	0.0026	CcSEcCtD
Glyburide—CYP2C9—female reproductive system—uterine cancer	0.000187	0.0043	CbGeAlD
Glyburide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000187	0.00258	CcSEcCtD
Glyburide—Jaundice—Etoposide—uterine cancer	0.000187	0.00258	CcSEcCtD
Glyburide—ABCG2—female gonad—uterine cancer	0.000186	0.00428	CbGeAlD
Glyburide—ABCG2—vagina—uterine cancer	0.000185	0.00425	CbGeAlD
Glyburide—Leukopenia—Dactinomycin—uterine cancer	0.000185	0.00256	CcSEcCtD
Glyburide—Aplastic anaemia—Epirubicin—uterine cancer	0.00018	0.00249	CcSEcCtD
Glyburide—Agranulocytosis—Etoposide—uterine cancer	0.000179	0.00247	CcSEcCtD
Glyburide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000178	0.00247	CcSEcCtD
Glyburide—CYP3A4—renal system—uterine cancer	0.000178	0.00409	CbGeAlD
Glyburide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000177	0.00245	CcSEcCtD
Glyburide—Myalgia—Dactinomycin—uterine cancer	0.000176	0.00244	CcSEcCtD
Glyburide—Hypersensitivity—Progesterone—uterine cancer	0.000176	0.00243	CcSEcCtD
Glyburide—ALB—lymph node—uterine cancer	0.000175	0.00403	CbGeAlD
Glyburide—ABCB1—myometrium—uterine cancer	0.000173	0.00398	CbGeAlD
Glyburide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000172	0.00238	CcSEcCtD
Glyburide—Asthenia—Progesterone—uterine cancer	0.000171	0.00237	CcSEcCtD
Glyburide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000171	0.00237	CcSEcCtD
Glyburide—Pruritus—Progesterone—uterine cancer	0.000169	0.00234	CcSEcCtD
Glyburide—Oedema—Dactinomycin—uterine cancer	0.000169	0.00234	CcSEcCtD
Glyburide—Aplastic anaemia—Doxorubicin—uterine cancer	0.000167	0.00231	CcSEcCtD
Glyburide—Thrombocytopenia—Dactinomycin—uterine cancer	0.000165	0.00229	CcSEcCtD
Glyburide—ABCC2—lymph node—uterine cancer	0.000164	0.00377	CbGeAlD
Glyburide—Diarrhoea—Progesterone—uterine cancer	0.000164	0.00226	CcSEcCtD
Glyburide—Anorexia—Dactinomycin—uterine cancer	0.000161	0.00223	CcSEcCtD
Glyburide—Eye disorder—Etoposide—uterine cancer	0.000161	0.00222	CcSEcCtD
Glyburide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00016	0.00221	CcSEcCtD
Glyburide—Hepatic function abnormal—Epirubicin—uterine cancer	0.00016	0.00221	CcSEcCtD
Glyburide—Vascular purpura—Epirubicin—uterine cancer	0.000156	0.00215	CcSEcCtD
Glyburide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000155	0.00215	CcSEcCtD
Glyburide—Hepatic failure—Epirubicin—uterine cancer	0.000155	0.00214	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000154	0.00213	CcSEcCtD
Glyburide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000153	0.00212	CcSEcCtD
Glyburide—Alopecia—Etoposide—uterine cancer	0.000152	0.0021	CcSEcCtD
Glyburide—Vomiting—Progesterone—uterine cancer	0.000152	0.0021	CcSEcCtD
Glyburide—Renal failure acute—Epirubicin—uterine cancer	0.000151	0.00209	CcSEcCtD
Glyburide—Rash—Progesterone—uterine cancer	0.000151	0.00208	CcSEcCtD
Glyburide—Dermatitis—Progesterone—uterine cancer	0.000151	0.00208	CcSEcCtD
Glyburide—Headache—Progesterone—uterine cancer	0.00015	0.00207	CcSEcCtD
Glyburide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000148	0.00205	CcSEcCtD
Glyburide—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000148	0.00204	CcSEcCtD
Glyburide—Decreased appetite—Dactinomycin—uterine cancer	0.000147	0.00203	CcSEcCtD
Glyburide—Renal impairment—Epirubicin—uterine cancer	0.000147	0.00203	CcSEcCtD
Glyburide—SLC15A2—lymph node—uterine cancer	0.000146	0.00336	CbGeAlD
Glyburide—Dermatitis bullous—Epirubicin—uterine cancer	0.000146	0.00202	CcSEcCtD
Glyburide—ABCC1—lymph node—uterine cancer	0.000145	0.00332	CbGeAlD
Glyburide—Purpura—Epirubicin—uterine cancer	0.000145	0.002	CcSEcCtD
Glyburide—Vascular purpura—Doxorubicin—uterine cancer	0.000144	0.00199	CcSEcCtD
Glyburide—Hepatic failure—Doxorubicin—uterine cancer	0.000144	0.00198	CcSEcCtD
Glyburide—Hypoglycaemia—Epirubicin—uterine cancer	0.000143	0.00198	CcSEcCtD
Glyburide—CYP3A4—female reproductive system—uterine cancer	0.000143	0.00328	CbGeAlD
Glyburide—Nausea—Progesterone—uterine cancer	0.000142	0.00196	CcSEcCtD
Glyburide—Hyponatraemia—Epirubicin—uterine cancer	0.00014	0.00194	CcSEcCtD
Glyburide—Renal failure acute—Doxorubicin—uterine cancer	0.00014	0.00193	CcSEcCtD
Glyburide—Diplopia—Epirubicin—uterine cancer	0.000139	0.00193	CcSEcCtD
Glyburide—Feeling abnormal—Dactinomycin—uterine cancer	0.000139	0.00192	CcSEcCtD
Glyburide—Anaemia—Etoposide—uterine cancer	0.000138	0.00191	CcSEcCtD
Glyburide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000138	0.00191	CcSEcCtD
Glyburide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000138	0.0019	CcSEcCtD
Glyburide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000137	0.00189	CcSEcCtD
Glyburide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000136	0.00189	CcSEcCtD
Glyburide—ABCB1—epithelium—uterine cancer	0.000136	0.00312	CbGeAlD
Glyburide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000136	0.00188	CcSEcCtD
Glyburide—Renal impairment—Doxorubicin—uterine cancer	0.000136	0.00187	CcSEcCtD
Glyburide—Dermatitis bullous—Doxorubicin—uterine cancer	0.000135	0.00187	CcSEcCtD
Glyburide—ABCB1—uterine cervix—uterine cancer	0.000135	0.0031	CbGeAlD
Glyburide—Leukopenia—Etoposide—uterine cancer	0.000134	0.00185	CcSEcCtD
Glyburide—Purpura—Doxorubicin—uterine cancer	0.000134	0.00185	CcSEcCtD
Glyburide—Abdominal pain—Dactinomycin—uterine cancer	0.000134	0.00185	CcSEcCtD
Glyburide—Hypoglycaemia—Doxorubicin—uterine cancer	0.000132	0.00183	CcSEcCtD
Glyburide—Convulsion—Etoposide—uterine cancer	0.00013	0.00179	CcSEcCtD
Glyburide—Hyponatraemia—Doxorubicin—uterine cancer	0.00013	0.00179	CcSEcCtD
Glyburide—Diplopia—Doxorubicin—uterine cancer	0.000129	0.00178	CcSEcCtD
Glyburide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000129	0.00178	CcSEcCtD
Glyburide—ABCB1—decidua—uterine cancer	0.000129	0.00295	CbGeAlD
Glyburide—ABCB1—renal system—uterine cancer	0.000126	0.0029	CbGeAlD
Glyburide—Hypersensitivity—Dactinomycin—uterine cancer	0.000124	0.00172	CcSEcCtD
Glyburide—Confusional state—Etoposide—uterine cancer	0.000123	0.0017	CcSEcCtD
Glyburide—ABCB1—endometrium—uterine cancer	0.000122	0.0028	CbGeAlD
Glyburide—Abdominal distension—Epirubicin—uterine cancer	0.000121	0.00168	CcSEcCtD
Glyburide—Asthenia—Dactinomycin—uterine cancer	0.000121	0.00168	CcSEcCtD
Glyburide—ABCG2—lymph node—uterine cancer	0.00012	0.00275	CbGeAlD
Glyburide—Thrombocytopenia—Etoposide—uterine cancer	0.00012	0.00165	CcSEcCtD
Glyburide—Eosinophilia—Epirubicin—uterine cancer	0.000119	0.00165	CcSEcCtD
Glyburide—Hyperhidrosis—Etoposide—uterine cancer	0.000118	0.00163	CcSEcCtD
Glyburide—Pancreatitis—Epirubicin—uterine cancer	0.000118	0.00163	CcSEcCtD
Glyburide—ABCB1—mammalian vulva—uterine cancer	0.000118	0.00271	CbGeAlD
Glyburide—Anorexia—Etoposide—uterine cancer	0.000117	0.00161	CcSEcCtD
Glyburide—Diarrhoea—Dactinomycin—uterine cancer	0.000116	0.0016	CcSEcCtD
Glyburide—Pancytopenia—Epirubicin—uterine cancer	0.000114	0.00158	CcSEcCtD
Glyburide—Hypotension—Etoposide—uterine cancer	0.000114	0.00158	CcSEcCtD
Glyburide—ABCB1—uterus—uterine cancer	0.000112	0.00258	CbGeAlD
Glyburide—Abdominal distension—Doxorubicin—uterine cancer	0.000112	0.00155	CcSEcCtD
Glyburide—Eosinophilia—Doxorubicin—uterine cancer	0.00011	0.00153	CcSEcCtD
Glyburide—Photosensitivity reaction—Epirubicin—uterine cancer	0.00011	0.00152	CcSEcCtD
Glyburide—Paraesthesia—Etoposide—uterine cancer	0.00011	0.00152	CcSEcCtD
Glyburide—Pancreatitis—Doxorubicin—uterine cancer	0.000109	0.00151	CcSEcCtD
Glyburide—Dyspnoea—Etoposide—uterine cancer	0.000109	0.00151	CcSEcCtD
Glyburide—Vomiting—Dactinomycin—uterine cancer	0.000107	0.00148	CcSEcCtD
Glyburide—Rash—Dactinomycin—uterine cancer	0.000107	0.00147	CcSEcCtD
Glyburide—Decreased appetite—Etoposide—uterine cancer	0.000106	0.00147	CcSEcCtD
Glyburide—Pancytopenia—Doxorubicin—uterine cancer	0.000106	0.00146	CcSEcCtD
Glyburide—Gastrointestinal disorder—Etoposide—uterine cancer	0.000106	0.00146	CcSEcCtD
Glyburide—Jaundice—Epirubicin—uterine cancer	0.000105	0.00145	CcSEcCtD
Glyburide—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000102	0.00141	CcSEcCtD
Glyburide—ABCB1—female reproductive system—uterine cancer	0.000101	0.00232	CbGeAlD
Glyburide—Feeling abnormal—Etoposide—uterine cancer	0.000101	0.00139	CcSEcCtD
Glyburide—Nausea—Dactinomycin—uterine cancer	0.0001	0.00139	CcSEcCtD
Glyburide—Agranulocytosis—Epirubicin—uterine cancer	0.0001	0.00139	CcSEcCtD
Glyburide—Gastrointestinal pain—Etoposide—uterine cancer	0.0001	0.00138	CcSEcCtD
Glyburide—Urticaria—Etoposide—uterine cancer	9.71e-05	0.00134	CcSEcCtD
Glyburide—Jaundice—Doxorubicin—uterine cancer	9.69e-05	0.00134	CcSEcCtD
Glyburide—Abdominal pain—Etoposide—uterine cancer	9.66e-05	0.00134	CcSEcCtD
Glyburide—Hepatitis—Epirubicin—uterine cancer	9.65e-05	0.00133	CcSEcCtD
Glyburide—Visual impairment—Epirubicin—uterine cancer	9.3e-05	0.00128	CcSEcCtD
Glyburide—Agranulocytosis—Doxorubicin—uterine cancer	9.28e-05	0.00128	CcSEcCtD
Glyburide—ABCB1—female gonad—uterine cancer	9.2e-05	0.00211	CbGeAlD
Glyburide—ABCB1—vagina—uterine cancer	9.14e-05	0.0021	CbGeAlD
Glyburide—Eye disorder—Epirubicin—uterine cancer	9.01e-05	0.00125	CcSEcCtD
Glyburide—Hypersensitivity—Etoposide—uterine cancer	9.01e-05	0.00125	CcSEcCtD
Glyburide—Hepatitis—Doxorubicin—uterine cancer	8.92e-05	0.00123	CcSEcCtD
Glyburide—Asthenia—Etoposide—uterine cancer	8.77e-05	0.00121	CcSEcCtD
Glyburide—Pruritus—Etoposide—uterine cancer	8.65e-05	0.0012	CcSEcCtD
Glyburide—Visual impairment—Doxorubicin—uterine cancer	8.6e-05	0.00119	CcSEcCtD
Glyburide—Alopecia—Epirubicin—uterine cancer	8.52e-05	0.00118	CcSEcCtD
Glyburide—Erythema—Epirubicin—uterine cancer	8.4e-05	0.00116	CcSEcCtD
Glyburide—Malnutrition—Epirubicin—uterine cancer	8.4e-05	0.00116	CcSEcCtD
Glyburide—Diarrhoea—Etoposide—uterine cancer	8.36e-05	0.00116	CcSEcCtD
Glyburide—Eye disorder—Doxorubicin—uterine cancer	8.34e-05	0.00115	CcSEcCtD
Glyburide—Vision blurred—Epirubicin—uterine cancer	7.91e-05	0.00109	CcSEcCtD
Glyburide—Alopecia—Doxorubicin—uterine cancer	7.89e-05	0.00109	CcSEcCtD
Glyburide—Vomiting—Etoposide—uterine cancer	7.77e-05	0.00107	CcSEcCtD
Glyburide—Malnutrition—Doxorubicin—uterine cancer	7.77e-05	0.00107	CcSEcCtD
Glyburide—Erythema—Doxorubicin—uterine cancer	7.77e-05	0.00107	CcSEcCtD
Glyburide—Anaemia—Epirubicin—uterine cancer	7.76e-05	0.00107	CcSEcCtD
Glyburide—Rash—Etoposide—uterine cancer	7.71e-05	0.00107	CcSEcCtD
Glyburide—Dermatitis—Etoposide—uterine cancer	7.7e-05	0.00106	CcSEcCtD
Glyburide—Headache—Etoposide—uterine cancer	7.66e-05	0.00106	CcSEcCtD
Glyburide—Leukopenia—Epirubicin—uterine cancer	7.52e-05	0.00104	CcSEcCtD
Glyburide—Vision blurred—Doxorubicin—uterine cancer	7.32e-05	0.00101	CcSEcCtD
Glyburide—Convulsion—Epirubicin—uterine cancer	7.28e-05	0.00101	CcSEcCtD
Glyburide—Nausea—Etoposide—uterine cancer	7.26e-05	0.001	CcSEcCtD
Glyburide—Anaemia—Doxorubicin—uterine cancer	7.18e-05	0.000993	CcSEcCtD
Glyburide—Myalgia—Epirubicin—uterine cancer	7.15e-05	0.000988	CcSEcCtD
Glyburide—Arthralgia—Epirubicin—uterine cancer	7.15e-05	0.000988	CcSEcCtD
Glyburide—Leukopenia—Doxorubicin—uterine cancer	6.95e-05	0.000961	CcSEcCtD
Glyburide—Confusional state—Epirubicin—uterine cancer	6.91e-05	0.000955	CcSEcCtD
Glyburide—Oedema—Epirubicin—uterine cancer	6.85e-05	0.000947	CcSEcCtD
Glyburide—Shock—Epirubicin—uterine cancer	6.74e-05	0.000932	CcSEcCtD
Glyburide—Convulsion—Doxorubicin—uterine cancer	6.73e-05	0.000931	CcSEcCtD
Glyburide—Nervous system disorder—Epirubicin—uterine cancer	6.72e-05	0.000929	CcSEcCtD
Glyburide—Thrombocytopenia—Epirubicin—uterine cancer	6.71e-05	0.000928	CcSEcCtD
Glyburide—Hyperhidrosis—Epirubicin—uterine cancer	6.62e-05	0.000916	CcSEcCtD
Glyburide—Myalgia—Doxorubicin—uterine cancer	6.61e-05	0.000914	CcSEcCtD
Glyburide—Arthralgia—Doxorubicin—uterine cancer	6.61e-05	0.000914	CcSEcCtD
Glyburide—Anorexia—Epirubicin—uterine cancer	6.53e-05	0.000903	CcSEcCtD
Glyburide—Hypotension—Epirubicin—uterine cancer	6.4e-05	0.000885	CcSEcCtD
Glyburide—Confusional state—Doxorubicin—uterine cancer	6.39e-05	0.000884	CcSEcCtD
Glyburide—Oedema—Doxorubicin—uterine cancer	6.34e-05	0.000877	CcSEcCtD
Glyburide—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.24e-05	0.000863	CcSEcCtD
Glyburide—Shock—Doxorubicin—uterine cancer	6.24e-05	0.000862	CcSEcCtD
Glyburide—Nervous system disorder—Doxorubicin—uterine cancer	6.22e-05	0.00086	CcSEcCtD
Glyburide—Thrombocytopenia—Doxorubicin—uterine cancer	6.21e-05	0.000858	CcSEcCtD
Glyburide—Paraesthesia—Epirubicin—uterine cancer	6.15e-05	0.000851	CcSEcCtD
Glyburide—Hyperhidrosis—Doxorubicin—uterine cancer	6.13e-05	0.000847	CcSEcCtD
Glyburide—Dyspnoea—Epirubicin—uterine cancer	6.11e-05	0.000845	CcSEcCtD
Glyburide—Anorexia—Doxorubicin—uterine cancer	6.04e-05	0.000836	CcSEcCtD
Glyburide—Dyspepsia—Epirubicin—uterine cancer	6.03e-05	0.000834	CcSEcCtD
Glyburide—Decreased appetite—Epirubicin—uterine cancer	5.96e-05	0.000824	CcSEcCtD
Glyburide—Hypotension—Doxorubicin—uterine cancer	5.92e-05	0.000819	CcSEcCtD
Glyburide—Gastrointestinal disorder—Epirubicin—uterine cancer	5.92e-05	0.000818	CcSEcCtD
Glyburide—ABCB1—lymph node—uterine cancer	5.91e-05	0.00136	CbGeAlD
Glyburide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.78e-05	0.000799	CcSEcCtD
Glyburide—Paraesthesia—Doxorubicin—uterine cancer	5.69e-05	0.000787	CcSEcCtD
Glyburide—Dyspnoea—Doxorubicin—uterine cancer	5.65e-05	0.000781	CcSEcCtD
Glyburide—Feeling abnormal—Epirubicin—uterine cancer	5.65e-05	0.000781	CcSEcCtD
Glyburide—Gastrointestinal pain—Epirubicin—uterine cancer	5.6e-05	0.000775	CcSEcCtD
Glyburide—Dyspepsia—Doxorubicin—uterine cancer	5.58e-05	0.000772	CcSEcCtD
Glyburide—Decreased appetite—Doxorubicin—uterine cancer	5.51e-05	0.000762	CcSEcCtD
Glyburide—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.47e-05	0.000757	CcSEcCtD
Glyburide—Urticaria—Epirubicin—uterine cancer	5.44e-05	0.000753	CcSEcCtD
Glyburide—Abdominal pain—Epirubicin—uterine cancer	5.42e-05	0.000749	CcSEcCtD
Glyburide—Feeling abnormal—Doxorubicin—uterine cancer	5.23e-05	0.000722	CcSEcCtD
Glyburide—Gastrointestinal pain—Doxorubicin—uterine cancer	5.19e-05	0.000717	CcSEcCtD
Glyburide—Hypersensitivity—Epirubicin—uterine cancer	5.05e-05	0.000698	CcSEcCtD
Glyburide—Urticaria—Doxorubicin—uterine cancer	5.04e-05	0.000696	CcSEcCtD
Glyburide—Abdominal pain—Doxorubicin—uterine cancer	5.01e-05	0.000693	CcSEcCtD
Glyburide—Asthenia—Epirubicin—uterine cancer	4.92e-05	0.00068	CcSEcCtD
Glyburide—Pruritus—Epirubicin—uterine cancer	4.85e-05	0.00067	CcSEcCtD
Glyburide—Diarrhoea—Epirubicin—uterine cancer	4.69e-05	0.000648	CcSEcCtD
Glyburide—Hypersensitivity—Doxorubicin—uterine cancer	4.67e-05	0.000646	CcSEcCtD
Glyburide—Asthenia—Doxorubicin—uterine cancer	4.55e-05	0.000629	CcSEcCtD
Glyburide—Pruritus—Doxorubicin—uterine cancer	4.49e-05	0.00062	CcSEcCtD
Glyburide—Vomiting—Epirubicin—uterine cancer	4.36e-05	0.000602	CcSEcCtD
Glyburide—Diarrhoea—Doxorubicin—uterine cancer	4.34e-05	0.0006	CcSEcCtD
Glyburide—Rash—Epirubicin—uterine cancer	4.32e-05	0.000597	CcSEcCtD
Glyburide—Dermatitis—Epirubicin—uterine cancer	4.32e-05	0.000597	CcSEcCtD
Glyburide—Headache—Epirubicin—uterine cancer	4.29e-05	0.000593	CcSEcCtD
Glyburide—Nausea—Epirubicin—uterine cancer	4.07e-05	0.000563	CcSEcCtD
Glyburide—Vomiting—Doxorubicin—uterine cancer	4.03e-05	0.000557	CcSEcCtD
Glyburide—Rash—Doxorubicin—uterine cancer	4e-05	0.000553	CcSEcCtD
Glyburide—Dermatitis—Doxorubicin—uterine cancer	3.99e-05	0.000552	CcSEcCtD
Glyburide—Headache—Doxorubicin—uterine cancer	3.97e-05	0.000549	CcSEcCtD
Glyburide—Nausea—Doxorubicin—uterine cancer	3.77e-05	0.000521	CcSEcCtD
Glyburide—SLCO1A2—Metabolism—POLD1—uterine cancer	1.69e-05	0.000387	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—RRM2—uterine cancer	1.69e-05	0.000387	CbGpPWpGaD
Glyburide—ABCB1—Allograft Rejection—VEGFA—uterine cancer	1.67e-05	0.000383	CbGpPWpGaD
Glyburide—ALB—Folate Metabolism—TP53—uterine cancer	1.66e-05	0.000381	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—DCN—uterine cancer	1.64e-05	0.000376	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—RRM2—uterine cancer	1.62e-05	0.000371	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKR1C1—uterine cancer	1.58e-05	0.000362	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—DCN—uterine cancer	1.57e-05	0.00036	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.56e-05	0.000357	CbGpPWpGaD
Glyburide—ABCC8—Neuronal System—HRAS—uterine cancer	1.56e-05	0.000357	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CYP11A1—uterine cancer	1.54e-05	0.000354	CbGpPWpGaD
Glyburide—CPT1A—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.54e-05	0.000353	CbGpPWpGaD
Glyburide—ABCA1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.54e-05	0.000353	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—POLD1—uterine cancer	1.52e-05	0.000349	CbGpPWpGaD
Glyburide—KCNJ11—Neuronal System—HRAS—uterine cancer	1.51e-05	0.000346	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CYP11A1—uterine cancer	1.48e-05	0.000339	CbGpPWpGaD
Glyburide—ABCC1—Disease—DCN—uterine cancer	1.47e-05	0.000337	CbGpPWpGaD
Glyburide—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.46e-05	0.000335	CbGpPWpGaD
Glyburide—ALB—Hemostasis—IRF1—uterine cancer	1.46e-05	0.000334	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKR1C3—uterine cancer	1.46e-05	0.000334	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.46e-05	0.000334	CbGpPWpGaD
Glyburide—ALB—Metabolism—NDUFB11—uterine cancer	1.46e-05	0.000334	CbGpPWpGaD
Glyburide—ALB—Metabolism—SRD5A2—uterine cancer	1.46e-05	0.000334	CbGpPWpGaD
Glyburide—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.44e-05	0.000331	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—STK11—uterine cancer	1.44e-05	0.000329	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—CYP19A1—uterine cancer	1.44e-05	0.000329	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKR1C1—uterine cancer	1.42e-05	0.000326	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.42e-05	0.000325	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.41e-05	0.000324	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—RRM2—uterine cancer	1.41e-05	0.000323	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKR1C3—uterine cancer	1.4e-05	0.00032	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—STK11—uterine cancer	1.39e-05	0.000319	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—CYP19A1—uterine cancer	1.39e-05	0.000319	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—DCN—uterine cancer	1.37e-05	0.000314	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—POLD1—uterine cancer	1.34e-05	0.000307	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.33e-05	0.000306	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKR1C3—uterine cancer	1.31e-05	0.0003	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.31e-05	0.000299	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.31e-05	0.000299	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CYP11A1—uterine cancer	1.29e-05	0.000295	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—NDUFB11—uterine cancer	1.28e-05	0.000292	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—SRD5A2—uterine cancer	1.28e-05	0.000292	CbGpPWpGaD
Glyburide—ABCC1—Disease—HMGA1—uterine cancer	1.27e-05	0.000292	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.27e-05	0.000291	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—RRM2—uterine cancer	1.27e-05	0.000291	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKR1C1—uterine cancer	1.25e-05	0.000287	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—DCN—uterine cancer	1.23e-05	0.000282	CbGpPWpGaD
Glyburide—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.23e-05	0.000282	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKR1C3—uterine cancer	1.22e-05	0.000279	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.2e-05	0.000275	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.19e-05	0.000273	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.19e-05	0.000273	CbGpPWpGaD
Glyburide—ABCC1—Disease—FBXW7—uterine cancer	1.17e-05	0.000267	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CYP11A1—uterine cancer	1.16e-05	0.000266	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.16e-05	0.000265	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—STK11—uterine cancer	1.14e-05	0.00026	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—CYP19A1—uterine cancer	1.14e-05	0.00026	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—RRM2—uterine cancer	1.12e-05	0.000256	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKR1C3—uterine cancer	1.09e-05	0.000251	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.09e-05	0.00025	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—STK11—uterine cancer	1.09e-05	0.00025	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—CYP19A1—uterine cancer	1.09e-05	0.00025	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—DCN—uterine cancer	1.08e-05	0.000248	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—MTHFR—uterine cancer	1.08e-05	0.000247	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.07e-05	0.000245	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.07e-05	0.000244	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKR1B1—uterine cancer	1.05e-05	0.000241	CbGpPWpGaD
Glyburide—ALB—Metabolism—STAR—uterine cancer	1.05e-05	0.000241	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—MTHFR—uterine cancer	1.05e-05	0.00024	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.04e-05	0.000238	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.02e-05	0.000234	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CYP11A1—uterine cancer	1.02e-05	0.000234	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.02e-05	0.000233	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	9.91e-06	0.000227	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.74e-06	0.000223	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PTEN—uterine cancer	9.72e-06	0.000223	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PTEN—uterine cancer	9.72e-06	0.000223	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKR1C3—uterine cancer	9.63e-06	0.000221	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—CYP19A1—uterine cancer	9.48e-06	0.000217	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—STK11—uterine cancer	9.48e-06	0.000217	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKR1B1—uterine cancer	9.44e-06	0.000217	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—STAR—uterine cancer	9.44e-06	0.000217	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	9.36e-06	0.000215	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	9.34e-06	0.000214	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—EP300—uterine cancer	9.27e-06	0.000213	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—EP300—uterine cancer	9.27e-06	0.000213	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—STAR—uterine cancer	9.22e-06	0.000211	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKR1B1—uterine cancer	9.22e-06	0.000211	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN2B—uterine cancer	9.13e-06	0.000209	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	9.12e-06	0.000209	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.9e-06	0.000204	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	8.7e-06	0.000199	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKR1B1—uterine cancer	8.61e-06	0.000197	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—STAR—uterine cancer	8.61e-06	0.000197	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—MTHFR—uterine cancer	8.53e-06	0.000196	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—CYP19A1—uterine cancer	8.53e-06	0.000196	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—STK11—uterine cancer	8.53e-06	0.000196	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	8.51e-06	0.000195	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.49e-06	0.000195	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	8.37e-06	0.000192	CbGpPWpGaD
Glyburide—ABCC1—Disease—SMAD3—uterine cancer	8.34e-06	0.000191	CbGpPWpGaD
Glyburide—ALB—Metabolism—POLD1—uterine cancer	8.26e-06	0.000189	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	8.24e-06	0.000189	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—MTHFR—uterine cancer	8.18e-06	0.000188	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.01e-06	0.000184	CbGpPWpGaD
Glyburide—ABCC1—Disease—FGFR2—uterine cancer	7.95e-06	0.000182	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—SRD5A2—uterine cancer	7.86e-06	0.00018	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—NDUFB11—uterine cancer	7.86e-06	0.00018	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKR1C1—uterine cancer	7.72e-06	0.000177	CbGpPWpGaD
Glyburide—ABCC1—Disease—MTHFR—uterine cancer	7.65e-06	0.000175	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.64e-06	0.000175	CbGpPWpGaD
Glyburide—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.52e-06	0.000172	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—CYP19A1—uterine cancer	7.51e-06	0.000172	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—STK11—uterine cancer	7.51e-06	0.000172	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—POLD1—uterine cancer	7.41e-06	0.00017	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—POLD1—uterine cancer	7.23e-06	0.000166	CbGpPWpGaD
Glyburide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.21e-06	0.000165	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—MTHFR—uterine cancer	7.12e-06	0.000163	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	7e-06	0.000161	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKR1C1—uterine cancer	6.93e-06	0.000159	CbGpPWpGaD
Glyburide—ALB—Metabolism—RRM2—uterine cancer	6.88e-06	0.000158	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—PIK3CA—uterine cancer	6.86e-06	0.000157	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—PIK3CA—uterine cancer	6.86e-06	0.000157	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKR1C1—uterine cancer	6.77e-06	0.000155	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—POLD1—uterine cancer	6.76e-06	0.000155	CbGpPWpGaD
Glyburide—ALB—Metabolism—DCN—uterine cancer	6.68e-06	0.000153	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	6.54e-06	0.00015	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	6.44e-06	0.000148	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—MTHFR—uterine cancer	6.41e-06	0.000147	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKR1C1—uterine cancer	6.32e-06	0.000145	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP11A1—uterine cancer	6.29e-06	0.000144	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.28e-06	0.000144	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	6.23e-06	0.000143	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—RRM2—uterine cancer	6.18e-06	0.000142	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—RRM2—uterine cancer	6.03e-06	0.000138	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PTEN—uterine cancer	6e-06	0.000138	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—DCN—uterine cancer	6e-06	0.000138	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKR1C3—uterine cancer	5.94e-06	0.000136	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—DCN—uterine cancer	5.85e-06	0.000134	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PTEN—uterine cancer	5.82e-06	0.000133	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—EP300—uterine cancer	5.73e-06	0.000131	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—STAR—uterine cancer	5.68e-06	0.00013	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKR1B1—uterine cancer	5.68e-06	0.00013	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP11A1—uterine cancer	5.65e-06	0.00013	CbGpPWpGaD
Glyburide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.65e-06	0.000129	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—MTHFR—uterine cancer	5.64e-06	0.000129	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—RRM2—uterine cancer	5.63e-06	0.000129	CbGpPWpGaD
Glyburide—ABCA1—Metabolism—AKT1—uterine cancer	5.6e-06	0.000128	CbGpPWpGaD
Glyburide—CPT1A—Metabolism—AKT1—uterine cancer	5.6e-06	0.000128	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—EP300—uterine cancer	5.55e-06	0.000127	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP11A1—uterine cancer	5.52e-06	0.000126	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—DCN—uterine cancer	5.47e-06	0.000125	CbGpPWpGaD
Glyburide—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	5.34e-06	0.000122	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKR1C3—uterine cancer	5.34e-06	0.000122	CbGpPWpGaD
Glyburide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.26e-06	0.000121	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKR1C3—uterine cancer	5.21e-06	0.000119	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP11A1—uterine cancer	5.15e-06	0.000118	CbGpPWpGaD
Glyburide—ABCC1—Disease—ERBB2—uterine cancer	4.99e-06	0.000114	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKR1C3—uterine cancer	4.87e-06	0.000112	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PTEN—uterine cancer	4.75e-06	0.000109	CbGpPWpGaD
Glyburide—ALB—Metabolism—STK11—uterine cancer	4.63e-06	0.000106	CbGpPWpGaD
Glyburide—ALB—Metabolism—CYP19A1—uterine cancer	4.63e-06	0.000106	CbGpPWpGaD
Glyburide—ABCC1—Disease—CDKN1B—uterine cancer	4.62e-06	0.000106	CbGpPWpGaD
Glyburide—ALB—Hemostasis—EP300—uterine cancer	4.55e-06	0.000104	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PTEN—uterine cancer	4.55e-06	0.000104	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—EP300—uterine cancer	4.53e-06	0.000104	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—POLD1—uterine cancer	4.46e-06	0.000102	CbGpPWpGaD
Glyburide—ABCC1—Disease—CTNNB1—uterine cancer	4.37e-06	0.0001	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.35e-06	9.97e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—EP300—uterine cancer	4.34e-06	9.95e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—VEGFA—uterine cancer	4.31e-06	9.89e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—NRAS—uterine cancer	4.26e-06	9.77e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PTEN—uterine cancer	4.26e-06	9.76e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—PIK3CA—uterine cancer	4.24e-06	9.71e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKR1C1—uterine cancer	4.17e-06	9.56e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—CYP19A1—uterine cancer	4.16e-06	9.53e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—STK11—uterine cancer	4.16e-06	9.53e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.15e-06	9.5e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—PIK3CA—uterine cancer	4.11e-06	9.42e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—EP300—uterine cancer	4.06e-06	9.31e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—STK11—uterine cancer	4.06e-06	9.3e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—CYP19A1—uterine cancer	4.06e-06	9.3e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PTEN—uterine cancer	3.96e-06	9.08e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.9e-06	8.95e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—NRAS—uterine cancer	3.8e-06	8.71e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—STK11—uterine cancer	3.79e-06	8.69e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—CYP19A1—uterine cancer	3.79e-06	8.69e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—EP300—uterine cancer	3.78e-06	8.66e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.72e-06	8.53e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—RRM2—uterine cancer	3.72e-06	8.52e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—KRAS—uterine cancer	3.67e-06	8.41e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—DCN—uterine cancer	3.61e-06	8.27e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PTEN—uterine cancer	3.57e-06	8.17e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.56e-06	8.16e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—MTHFR—uterine cancer	3.48e-06	7.98e-05	CbGpPWpGaD
Glyburide—ABCC8—Metabolism—AKT1—uterine cancer	3.46e-06	7.93e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—EP300—uterine cancer	3.4e-06	7.8e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP11A1—uterine cancer	3.4e-06	7.79e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.39e-06	7.78e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—PIK3CA—uterine cancer	3.37e-06	7.72e-05	CbGpPWpGaD
Glyburide—KCNJ11—Metabolism—AKT1—uterine cancer	3.36e-06	7.69e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—PIK3CA—uterine cancer	3.35e-06	7.68e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—KRAS—uterine cancer	3.27e-06	7.5e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—TP53—uterine cancer	3.26e-06	7.47e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—PIK3CA—uterine cancer	3.21e-06	7.36e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKR1C3—uterine cancer	3.21e-06	7.36e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PTEN—uterine cancer	3.14e-06	7.19e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—MTHFR—uterine cancer	3.12e-06	7.16e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—HRAS—uterine cancer	3.12e-06	7.15e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.07e-06	7.03e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—MTHFR—uterine cancer	3.05e-06	6.99e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—PIK3CA—uterine cancer	3e-06	6.89e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—EP300—uterine cancer	2.99e-06	6.86e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—MTHFR—uterine cancer	2.85e-06	6.53e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—PIK3CA—uterine cancer	2.8e-06	6.41e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—HRAS—uterine cancer	2.78e-06	6.37e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.75e-06	6.31e-05	CbGpPWpGaD
Glyburide—ALB—Hemostasis—AKT1—uterine cancer	2.75e-06	6.31e-05	CbGpPWpGaD
Glyburide—ABCB11—Metabolism—AKT1—uterine cancer	2.74e-06	6.27e-05	CbGpPWpGaD
Glyburide—ABCC3—Metabolism—AKT1—uterine cancer	2.62e-06	6.01e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—PIK3CA—uterine cancer	2.52e-06	5.77e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.51e-06	5.76e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—STK11—uterine cancer	2.5e-06	5.73e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—CYP19A1—uterine cancer	2.5e-06	5.73e-05	CbGpPWpGaD
Glyburide—ABCC1—Disease—AKT1—uterine cancer	2.45e-06	5.63e-05	CbGpPWpGaD
Glyburide—SLCO1A2—Metabolism—AKT1—uterine cancer	2.28e-06	5.24e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—PIK3CA—uterine cancer	2.21e-06	5.07e-05	CbGpPWpGaD
Glyburide—ABCC1—Metabolism—AKT1—uterine cancer	2.05e-06	4.71e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PTEN—uterine cancer	1.94e-06	4.44e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—MTHFR—uterine cancer	1.88e-06	4.31e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—EP300—uterine cancer	1.85e-06	4.23e-05	CbGpPWpGaD
Glyburide—ABCG2—Metabolism—AKT1—uterine cancer	1.81e-06	4.15e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PTEN—uterine cancer	1.74e-06	3.98e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PTEN—uterine cancer	1.7e-06	3.89e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—EP300—uterine cancer	1.66e-06	3.8e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—EP300—uterine cancer	1.62e-06	3.71e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PTEN—uterine cancer	1.58e-06	3.63e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—EP300—uterine cancer	1.51e-06	3.46e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—PIK3CA—uterine cancer	1.37e-06	3.13e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.23e-06	2.81e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—PIK3CA—uterine cancer	1.2e-06	2.74e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.12e-06	2.56e-05	CbGpPWpGaD
Glyburide—ALB—Metabolism—AKT1—uterine cancer	1.12e-06	2.56e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PTEN—uterine cancer	1.05e-06	2.4e-05	CbGpPWpGaD
Glyburide—CYP2C19—Metabolism—AKT1—uterine cancer	1e-06	2.3e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—EP300—uterine cancer	9.97e-07	2.29e-05	CbGpPWpGaD
Glyburide—ABCB1—Metabolism—AKT1—uterine cancer	9.78e-07	2.24e-05	CbGpPWpGaD
Glyburide—CYP2C9—Metabolism—AKT1—uterine cancer	9.13e-07	2.09e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—PIK3CA—uterine cancer	7.37e-07	1.69e-05	CbGpPWpGaD
Glyburide—CYP3A4—Metabolism—AKT1—uterine cancer	6.02e-07	1.38e-05	CbGpPWpGaD
